Showing 1 - 20 results of 23 for search 'JEEVAN, K.', query time: 0.07s
Refine Results
-
1
Cranberry polyphenols‐gut microbiota interactions and potential health benefits: An updated review by Jeevan K. Prasain, Stephen Barnes
Published 2020-12-01
Article -
2
-
3
Sperm-Guiding Unconventional Prostaglandins in <i>C. elegans</i>: Synthesis and Signaling by Ekta Tiwary, Muhan Hu, Jeevan K. Prasain
Published 2021-12-01
Article -
4
Ant System-Corner Insertion Sequence: An Efficient VLSI Hard Module Placer by HOO, C.-S., JEEVAN, K., GANAPATHY, V., RAMIAH, H.
Published 2013-02-01
Article -
5
Kudzu isoflavone C‐glycosides: Analysis, biological activities, and metabolism by Jeevan K. Prasain, Stephen Barnes, J. Michael Wyss
Published 2021-09-01
Article -
6
Bisalbuminemia in a Hypothyroid Patient with Diabetes: A Case Report by Jeevan K. Shetty, Ravindra Maradi, Krishnananda Prabhu, Gopalkrishna Bhat
Published 2015-09-01
Article -
7
-
8
-
9
Early Detection of Precancerous and Cancerous Lesions: An Overview by Jincy Thomas, Daniel Alex Vineet, P M Rasheena, Jeevan K Krishnan
Published 2013-01-01
Article -
10
-
11
Glutathione S-Transferase activity and total thiol status in chronic alcohol abusers before and 30 days after alcohol abstinence by Manjunatha S Muttigi, Lakshmi S Prabhu, Vivekananda Kedage, Mungli Prakash, Jeevan K Shetty, Devaramane Virupaksha, Panambur V Bhandary
Published 2009-05-01
Article -
12
The experiences of the landslide survivors from Kodagu District, India: Need for community-engaged village/ward level micro disaster management planning by Prabhath Matpady, Arun G. Maiya, Kiran K.V. Acharya, D.S. Anupama, Prashanth Bhagavat, Arathi P. Rao, Jeevan K. Shetty
Published 2023-09-01
Article -
13
-
14
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia by Antonio Piga, Filomena Longo, Maria Rita Gamberini, Ersi Voskaridou, Paolo Ricchi, Vincenzo Caruso, Antonello Pietrangelo, Xiaosha Zhang, Jeevan K. Shetty, Kenneth M. Attie, Immacolata Tartaglione
Published 2022-12-01
Article -
15
Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke by Nivedita L. Rao, Greeshma B. Kotian, Jeevan K. Shetty, Bhaskara P. Shelley, Mackwin Kenwood Dmello, Eric C. Lobo, Suchetha Padar Shankar, Shellette D. Almeida, Saiqa R. Shah
Published 2022-11-01
Article -
16
PB2535: TRIAL IN PROGRESS: A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LUSPATERCEPT TO TREAT ANEMIA IN ADULTS... by Vip Viprakasit, Yongrong Lai, Gian Luca Forni, Meng-Yao Lu, Liudi Yang, Wenhui Shi, Loyse Felber Medlin, Frederik Lersch, Jeevan K. Shetty, Luciana Moro Bueno, Richard Wei, Antonis Kattamis
Published 2023-08-01
Article -
17
P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL by Thomas D. Coates, Maria Domenica Cappellini, Sujit Sheth, Kevin H.M. Kuo, Antonio Giulio Piga, Antonis Kattamis, Martina Perin, Frederik Lersch, Jeevan K. Shetty, Yinzhi Lai, Wen-Ling Kuo, Ali T. Taher
Published 2023-08-01
Article -
18
Psychometric evaluation of the NTDT-PRO questionnaire for assessing symptoms in patients with non-transfusion-dependent beta-thalassaemia by Ali T Taher, Maria Domenica Cappellini, Khaled M Musallam, Vip Viprakasit, Antonis Kattamis, Jennifer Lord-Bessen, Aylin Yucel, Shien Guo, Christopher Pelligra, Alan L Shields, Jeevan K Shetty, Dimana Miteva, Luciana Moro Bueno
Published 2023-03-01
Article -
19
S273: LONG-TERM ERYTHROID RESPONSE DATA FROM PATIENTS (PTS) WITH NON-TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA (NTDT) RECEIVING LUSPATERCEPT IN THE BEYOND TRIAL by Ali T. Taher, Vip Viprakasit, Maria Domenica Cappellini, Antonio Giulio Piga, John B. Porter, Thomas D. Coates, Khaled M. Musallam, Gian Luca Forni, Jeevan K. Shetty, Marija Bosilkovska Weisskopf, Richard Wei, Wen-Ling Kuo, Antonis Kattamis
Published 2023-08-01
Article -
20
Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 Trial by Esther Natalie Oliva, Uwe Platzbecker, Guillermo Garcia-Manero, Ghulam J. Mufti, Valeria Santini, Mikkael A. Sekeres, Rami S. Komrokji, Jeevan K. Shetty, Derek Tang, Shien Guo, Weiqin Liao, George Zhang, Xianwei Ha, Rodrigo Ito, Jennifer Lord-Bessen, Jay T. Backstrom, Pierre Fenaux
Published 2021-12-01
Article